APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bromhidrosis Disease Treatment

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Bromhidrosis Disease Treatment Market Outlook and Growth Opportunities 2026

22 December 2025191 pages

Choose your research edition.

Industry ResearchBromhidrosis Disease Treatment Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Bromhidrosis Disease Treatment Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Bromhidrosis Disease Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bromhidrosis Disease Treatment Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Bromhidrosis Disease Treatment Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Bromhidrosis Disease Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Bromhidrosis Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bromhidrosis Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bromhidrosis Disease Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Bromhidrosis Disease Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Bromhidrosis Disease Treatment market include Johnson and Johnson, Novartis AG, Pfizer, AbbVie, Merz Pharma GmbH and Co. KGaA, Medytox, Journey Medical Corp, Ipsen Pharma and Hikma Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bromhidrosis Disease Treatment market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bromhidrosis Disease Treatment and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bromhidrosis Disease Treatment sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bromhidrosis Disease Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Bromhidrosis Disease Treatment Segment by Company

Johnson and Johnson

Novartis AG

Pfizer

AbbVie

Merz Pharma GmbH and Co. KGaA

Medytox

Journey Medical Corp

Ipsen Pharma

Hikma Pharmaceuticals

Galderma SA

Boehringer Ingelheim International GmbH

Biovencer Healthcare

Bromhidrosis Disease Treatment Segment by Type

Antiperspirants

Botulinum Toxin

Topical Antiseptic

Bromhidrosis Disease Treatment Segment by Application

Hospital

Drugs Store

Other

Bromhidrosis Disease Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Bromhidrosis Disease Treatment status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Bromhidrosis Disease Treatment market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Bromhidrosis Disease Treatment significant trends, drivers, influence factors in global and regions.

6. To analyze Bromhidrosis Disease Treatment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bromhidrosis Disease Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bromhidrosis Disease Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bromhidrosis Disease Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bromhidrosis Disease Treatment market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bromhidrosis Disease Treatment industry.

Chapter 3: Detailed analysis of Bromhidrosis Disease Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Bromhidrosis Disease Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Bromhidrosis Disease Treatment in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Bromhidrosis Disease Treatment Industry Trends Table 2. Bromhidrosis Disease Treatment Industry Drivers Table 3. Bromhidrosis Disease Treatment Industry Opportunities and Challenges Table 4. Bromhidrosis Disease Treatment Industry Restraints Table 5. Global Bromhidrosis Disease Treatment Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Bromhidrosis Disease Treatment Revenue Share by Company (2021-2026) Table 7. Global Bromhidrosis Disease Treatment Sales Volume by Company (k units) & (2021-2026) Table 8. Global Bromhidrosis Disease Treatment Sales Volume Share by Company (2021-2026) Table 9. Global Bromhidrosis Disease Treatment Average Price (US$/unit) of Company (2021-2026) Table 10. Global Bromhidrosis Disease Treatment Company Ranking, (2024-2026) & (USD Million) Table 11. Global Bromhidrosis Disease Treatment Key Company Manufacturing Base & Headquarters Table 12. Global Bromhidrosis Disease Treatment Company, Product Type & Application Table 13. Global Bromhidrosis Disease Treatment Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Bromhidrosis Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Antiperspirants Table 18. Significant Companies of Botulinum Toxin Table 19. Significant Companies of Topical Antiseptic Table 20. Global Bromhidrosis Disease Treatment Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Bromhidrosis Disease Treatment Sales Volume by Type (2021-2026) & (k units) Table 22. Global Bromhidrosis Disease Treatment Sales Volume by Type (2027-2032) & (k units) Table 23. Global Bromhidrosis Disease Treatment Sales Volume Share by Type (2021-2026) Table 24. Global Bromhidrosis Disease Treatment Sales Volume Share by Type (2027-2032) Table 25. Global Bromhidrosis Disease Treatment Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Bromhidrosis Disease Treatment Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Bromhidrosis Disease Treatment Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Bromhidrosis Disease Treatment Sales Value Share by Type (2021-2026) Table 29. Global Bromhidrosis Disease Treatment Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Drugs Store Table 32. Significant Companies of Other Table 33. Global Bromhidrosis Disease Treatment Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Bromhidrosis Disease Treatment Sales Volume by Application (2021-2026) & (k units) Table 35. Global Bromhidrosis Disease Treatment Sales Volume by Application (2027-2032) & (k units) Table 36. Global Bromhidrosis Disease Treatment Sales Volume Share by Application (2021-2026) Table 37. Global Bromhidrosis Disease Treatment Sales Volume Share by Application (2027-2032) Table 38. Global Bromhidrosis Disease Treatment Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Bromhidrosis Disease Treatment Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Bromhidrosis Disease Treatment Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Bromhidrosis Disease Treatment Sales Value Share by Application (2021-2026) Table 42. Global Bromhidrosis Disease Treatment Sales Value Share by Application (2027-2032) Table 43. Global Bromhidrosis Disease Treatment Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Bromhidrosis Disease Treatment Sales by Region (2021-2026) & (k units) Table 45. Global Bromhidrosis Disease Treatment Sales Market Share by Region (2021-2026) Table 46. Global Bromhidrosis Disease Treatment Sales by Region (2027-2032) & (k units) Table 47. Global Bromhidrosis Disease Treatment Sales Market Share by Region (2027-2032) Table 48. Global Bromhidrosis Disease Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Bromhidrosis Disease Treatment Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Bromhidrosis Disease Treatment Sales Value Share by Region (2021-2026) Table 51. Global Bromhidrosis Disease Treatment Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Bromhidrosis Disease Treatment Sales Value Share by Region (2027-2032) Table 53. Global Bromhidrosis Disease Treatment Market Average Price (US$/unit) by Region (2021-2026) Table 54. Global Bromhidrosis Disease Treatment Market Average Price (US$/unit) by Region (2027-2032) Table 55. Global Bromhidrosis Disease Treatment Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Bromhidrosis Disease Treatment Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Bromhidrosis Disease Treatment Sales by Country (2021-2026) & (k units) Table 58. Global Bromhidrosis Disease Treatment Sales Market Share by Country (2021-2026) Table 59. Global Bromhidrosis Disease Treatment Sales by Country (2027-2032) & (k units) Table 60. Global Bromhidrosis Disease Treatment Sales Market Share by Country (2027-2032) Table 61. Global Bromhidrosis Disease Treatment Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Bromhidrosis Disease Treatment Sales Value Market Share by Country (2021-2026) Table 63. Global Bromhidrosis Disease Treatment Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Bromhidrosis Disease Treatment Sales Value Market Share by Country (2027-2032) Table 65. Johnson and Johnson Company Information Table 66. Johnson and Johnson Business Overview Table 67. Johnson and Johnson Bromhidrosis Disease Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Johnson and Johnson Bromhidrosis Disease Treatment Product Portfolio Table 69. Johnson and Johnson Recent Development Table 70. Novartis AG Company Information Table 71. Novartis AG Business Overview Table 72. Novartis AG Bromhidrosis Disease Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Novartis AG Bromhidrosis Disease Treatment Product Portfolio Table 74. Novartis AG Recent Development Table 75. Pfizer Company Information Table 76. Pfizer Business Overview Table 77. Pfizer Bromhidrosis Disease Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Pfizer Bromhidrosis Disease Treatment Product Portfolio Table 79. Pfizer Recent Development Table 80. AbbVie Company Information Table 81. AbbVie Business Overview Table 82. AbbVie Bromhidrosis Disease Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. AbbVie Bromhidrosis Disease Treatment Product Portfolio Table 84. AbbVie Recent Development Table 85. Merz Pharma GmbH and Co. KGaA Company Information Table 86. Merz Pharma GmbH and Co. KGaA Business Overview Table 87. Merz Pharma GmbH and Co. KGaA Bromhidrosis Disease Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Merz Pharma GmbH and Co. KGaA Bromhidrosis Disease Treatment Product Portfolio Table 89. Merz Pharma GmbH and Co. KGaA Recent Development Table 90. Medytox Company Information Table 91. Medytox Business Overview Table 92. Medytox Bromhidrosis Disease Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Medytox Bromhidrosis Disease Treatment Product Portfolio Table 94. Medytox Recent Development Table 95. Journey Medical Corp Company Information Table 96. Journey Medical Corp Business Overview Table 97. Journey Medical Corp Bromhidrosis Disease Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Journey Medical Corp Bromhidrosis Disease Treatment Product Portfolio Table 99. Journey Medical Corp Recent Development Table 100. Ipsen Pharma Company Information Table 101. Ipsen Pharma Business Overview Table 102. Ipsen Pharma Bromhidrosis Disease Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Ipsen Pharma Bromhidrosis Disease Treatment Product Portfolio Table 104. Ipsen Pharma Recent Development Table 105. Hikma Pharmaceuticals Company Information Table 106. Hikma Pharmaceuticals Business Overview Table 107. Hikma Pharmaceuticals Bromhidrosis Disease Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. Hikma Pharmaceuticals Bromhidrosis Disease Treatment Product Portfolio Table 109. Hikma Pharmaceuticals Recent Development Table 110. Galderma SA Company Information Table 111. Galderma SA Business Overview Table 112. Galderma SA Bromhidrosis Disease Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Galderma SA Bromhidrosis Disease Treatment Product Portfolio Table 114. Galderma SA Recent Development Table 115. Boehringer Ingelheim International GmbH Company Information Table 116. Boehringer Ingelheim International GmbH Business Overview Table 117. Boehringer Ingelheim International GmbH Bromhidrosis Disease Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. Boehringer Ingelheim International GmbH Bromhidrosis Disease Treatment Product Portfolio Table 119. Boehringer Ingelheim International GmbH Recent Development Table 120. Biovencer Healthcare Company Information Table 121. Biovencer Healthcare Business Overview Table 122. Biovencer Healthcare Bromhidrosis Disease Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 123. Biovencer Healthcare Bromhidrosis Disease Treatment Product Portfolio Table 124. Biovencer Healthcare Recent Development Table 125. Key Raw Materials Table 126. Raw Materials Key Suppliers Table 127. Bromhidrosis Disease Treatment Distributors List Table 128. Bromhidrosis Disease Treatment Customers List Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Bromhidrosis Disease Treatment Product Image Figure 2. Global Bromhidrosis Disease Treatment Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bromhidrosis Disease Treatment Sales Value (2021-2032) & (US$ Million) Figure 4. Global Bromhidrosis Disease Treatment Sales (2021-2032) & (k units) Figure 5. Global Bromhidrosis Disease Treatment Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Bromhidrosis Disease Treatment Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Antiperspirants Image Figure 10. Botulinum Toxin Image Figure 11. Topical Antiseptic Image Figure 12. Global Bromhidrosis Disease Treatment Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Bromhidrosis Disease Treatment Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Bromhidrosis Disease Treatment Sales Volume Share by Type (2021-2032) Figure 15. Global Bromhidrosis Disease Treatment Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Bromhidrosis Disease Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Bromhidrosis Disease Treatment Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Drugs Store Image Figure 20. Other Image Figure 21. Global Bromhidrosis Disease Treatment Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Bromhidrosis Disease Treatment Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Bromhidrosis Disease Treatment Sales Volume Share by Application (2021-2032) Figure 24. Global Bromhidrosis Disease Treatment Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Bromhidrosis Disease Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Bromhidrosis Disease Treatment Sales Value Share by Application (2021-2032) Figure 27. Global Bromhidrosis Disease Treatment Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Bromhidrosis Disease Treatment Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Bromhidrosis Disease Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Bromhidrosis Disease Treatment Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Bromhidrosis Disease Treatment Sales Value (2021-2032) & (US$ Million) Figure 32. North America Bromhidrosis Disease Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Bromhidrosis Disease Treatment Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Bromhidrosis Disease Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Bromhidrosis Disease Treatment Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Bromhidrosis Disease Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Bromhidrosis Disease Treatment Sales Value (2021-2032) & (US$ Million) Figure 38. South America Bromhidrosis Disease Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Bromhidrosis Disease Treatment Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Bromhidrosis Disease Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Bromhidrosis Disease Treatment Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Bromhidrosis Disease Treatment Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Antiperspirants
  • Botulinum Toxin
  • Topical Antiseptic
Applications
  • Hospital
  • Drugs Store
  • Other
Companies covered
  • Johnson and Johnson
  • Novartis AG
  • Pfizer
  • AbbVie
  • Merz Pharma GmbH and Co. KGaA
  • Medytox
  • Journey Medical Corp
  • Ipsen Pharma
  • Hikma Pharmaceuticals
  • Galderma SA
  • Boehringer Ingelheim International GmbH
  • Biovencer Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bromhidrosis Disease Treatment Sales Value (2021-2032)
  4. 1.2.2 Global Bromhidrosis Disease Treatment Sales Volume (2021-2032)
  5. 1.2.3 Global Bromhidrosis Disease Treatment Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Bromhidrosis Disease Treatment Market Dynamics
  1. 2.1 Bromhidrosis Disease Treatment Industry Trends
  2. 2.2 Bromhidrosis Disease Treatment Industry Drivers
  3. 2.3 Bromhidrosis Disease Treatment Industry Opportunities and Challenges
  4. 2.4 Bromhidrosis Disease Treatment Industry Restraints
3 Bromhidrosis Disease Treatment Market by Company
  1. 3.1 Global Bromhidrosis Disease Treatment Company Revenue Ranking in 2025
  2. 3.2 Global Bromhidrosis Disease Treatment Revenue by Company (2021-2026)
  3. 3.3 Global Bromhidrosis Disease Treatment Sales Volume by Company (2021-2026)
  4. 3.4 Global Bromhidrosis Disease Treatment Average Price by Company (2021-2026)
  5. 3.5 Global Bromhidrosis Disease Treatment Company Ranking (2024-2026)
  6. 3.6 Global Bromhidrosis Disease Treatment Company Manufacturing Base and Headquarters
  7. 3.7 Global Bromhidrosis Disease Treatment Company Product Type and Application
  8. 3.8 Global Bromhidrosis Disease Treatment Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Bromhidrosis Disease Treatment Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Bromhidrosis Disease Treatment Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Bromhidrosis Disease Treatment Market by Type
  1. 4.1 Bromhidrosis Disease Treatment Type Introduction
  2. 4.1.1 Antiperspirants
  3. 4.1.2 Botulinum Toxin
  4. 4.1.3 Topical Antiseptic
  5. 4.2 Global Bromhidrosis Disease Treatment Sales Volume by Type
  6. 4.2.1 Global Bromhidrosis Disease Treatment Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Bromhidrosis Disease Treatment Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Bromhidrosis Disease Treatment Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Bromhidrosis Disease Treatment Sales Value by Type
  10. 4.3.1 Global Bromhidrosis Disease Treatment Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Bromhidrosis Disease Treatment Sales Value by Type (2021-2032)
  12. 4.3.3 Global Bromhidrosis Disease Treatment Sales Value Share by Type (2021-2032)
5 Bromhidrosis Disease Treatment Market by Application
  1. 5.1 Bromhidrosis Disease Treatment Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drugs Store
  4. 5.1.3 Other
  5. 5.2 Global Bromhidrosis Disease Treatment Sales Volume by Application
  6. 5.2.1 Global Bromhidrosis Disease Treatment Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Bromhidrosis Disease Treatment Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Bromhidrosis Disease Treatment Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Bromhidrosis Disease Treatment Sales Value by Application
  10. 5.3.1 Global Bromhidrosis Disease Treatment Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Bromhidrosis Disease Treatment Sales Value by Application (2021-2032)
  12. 5.3.3 Global Bromhidrosis Disease Treatment Sales Value Share by Application (2021-2032)
6 Bromhidrosis Disease Treatment Regional Sales and Value Analysis
  1. 6.1 Global Bromhidrosis Disease Treatment Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bromhidrosis Disease Treatment Sales by Region (2021-2032)
  3. 6.2.1 Global Bromhidrosis Disease Treatment Sales by Region: 2021-2026
  4. 6.2.2 Global Bromhidrosis Disease Treatment Sales by Region (2027-2032)
  5. 6.3 Global Bromhidrosis Disease Treatment Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Bromhidrosis Disease Treatment Sales Value by Region (2021-2032)
  7. 6.4.1 Global Bromhidrosis Disease Treatment Sales Value by Region: 2021-2026
  8. 6.4.2 Global Bromhidrosis Disease Treatment Sales Value by Region (2027-2032)
  9. 6.5 Global Bromhidrosis Disease Treatment Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Bromhidrosis Disease Treatment Sales Value (2021-2032)
  12. 6.6.2 North America Bromhidrosis Disease Treatment Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Bromhidrosis Disease Treatment Sales Value (2021-2032)
  15. 6.7.2 Europe Bromhidrosis Disease Treatment Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Bromhidrosis Disease Treatment Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Bromhidrosis Disease Treatment Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Bromhidrosis Disease Treatment Sales Value (2021-2032)
  21. 6.9.2 South America Bromhidrosis Disease Treatment Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Bromhidrosis Disease Treatment Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Bromhidrosis Disease Treatment Sales Value Share by Country, 2025 VS 2032
7 Bromhidrosis Disease Treatment Country-level Sales and Value Analysis
  1. 7.1 Global Bromhidrosis Disease Treatment Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Bromhidrosis Disease Treatment Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Bromhidrosis Disease Treatment Sales by Country (2021-2032)
  4. 7.3.1 Global Bromhidrosis Disease Treatment Sales by Country (2021-2026)
  5. 7.3.2 Global Bromhidrosis Disease Treatment Sales by Country (2027-2032)
  6. 7.4 Global Bromhidrosis Disease Treatment Sales Value by Country (2021-2032)
  7. 7.4.1 Global Bromhidrosis Disease Treatment Sales Value by Country (2021-2026)
  8. 7.4.2 Global Bromhidrosis Disease Treatment Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Bromhidrosis Disease Treatment Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Bromhidrosis Disease Treatment Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Bromhidrosis Disease Treatment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson and Johnson
  2. 8.1.1 Johnson and Johnson Company Information
  3. 8.1.2 Johnson and Johnson Business Overview
  4. 8.1.3 Johnson and Johnson Bromhidrosis Disease Treatment Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Johnson and Johnson Bromhidrosis Disease Treatment Product Portfolio
  6. 8.1.5 Johnson and Johnson Recent Developments
  7. 8.2 Novartis AG
  8. 8.2.1 Novartis AG Company Information
  9. 8.2.2 Novartis AG Business Overview
  10. 8.2.3 Novartis AG Bromhidrosis Disease Treatment Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Novartis AG Bromhidrosis Disease Treatment Product Portfolio
  12. 8.2.5 Novartis AG Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Bromhidrosis Disease Treatment Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Bromhidrosis Disease Treatment Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 AbbVie
  20. 8.4.1 AbbVie Company Information
  21. 8.4.2 AbbVie Business Overview
  22. 8.4.3 AbbVie Bromhidrosis Disease Treatment Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 AbbVie Bromhidrosis Disease Treatment Product Portfolio
  24. 8.4.5 AbbVie Recent Developments
  25. 8.5 Merz Pharma GmbH and Co. KGaA
  26. 8.5.1 Merz Pharma GmbH and Co. KGaA Company Information
  27. 8.5.2 Merz Pharma GmbH and Co. KGaA Business Overview
  28. 8.5.3 Merz Pharma GmbH and Co. KGaA Bromhidrosis Disease Treatment Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Merz Pharma GmbH and Co. KGaA Bromhidrosis Disease Treatment Product Portfolio
  30. 8.5.5 Merz Pharma GmbH and Co. KGaA Recent Developments
  31. 8.6 Medytox
  32. 8.6.1 Medytox Company Information
  33. 8.6.2 Medytox Business Overview
  34. 8.6.3 Medytox Bromhidrosis Disease Treatment Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Medytox Bromhidrosis Disease Treatment Product Portfolio
  36. 8.6.5 Medytox Recent Developments
  37. 8.7 Journey Medical Corp
  38. 8.7.1 Journey Medical Corp Company Information
  39. 8.7.2 Journey Medical Corp Business Overview
  40. 8.7.3 Journey Medical Corp Bromhidrosis Disease Treatment Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Journey Medical Corp Bromhidrosis Disease Treatment Product Portfolio
  42. 8.7.5 Journey Medical Corp Recent Developments
  43. 8.8 Ipsen Pharma
  44. 8.8.1 Ipsen Pharma Company Information
  45. 8.8.2 Ipsen Pharma Business Overview
  46. 8.8.3 Ipsen Pharma Bromhidrosis Disease Treatment Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Ipsen Pharma Bromhidrosis Disease Treatment Product Portfolio
  48. 8.8.5 Ipsen Pharma Recent Developments
  49. 8.9 Hikma Pharmaceuticals
  50. 8.9.1 Hikma Pharmaceuticals Company Information
  51. 8.9.2 Hikma Pharmaceuticals Business Overview
  52. 8.9.3 Hikma Pharmaceuticals Bromhidrosis Disease Treatment Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Hikma Pharmaceuticals Bromhidrosis Disease Treatment Product Portfolio
  54. 8.9.5 Hikma Pharmaceuticals Recent Developments
  55. 8.10 Galderma SA
  56. 8.10.1 Galderma SA Company Information
  57. 8.10.2 Galderma SA Business Overview
  58. 8.10.3 Galderma SA Bromhidrosis Disease Treatment Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Galderma SA Bromhidrosis Disease Treatment Product Portfolio
  60. 8.10.5 Galderma SA Recent Developments
  61. 8.11 Boehringer Ingelheim International GmbH
  62. 8.11.1 Boehringer Ingelheim International GmbH Company Information
  63. 8.11.2 Boehringer Ingelheim International GmbH Business Overview
  64. 8.11.3 Boehringer Ingelheim International GmbH Bromhidrosis Disease Treatment Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Boehringer Ingelheim International GmbH Bromhidrosis Disease Treatment Product Portfolio
  66. 8.11.5 Boehringer Ingelheim International GmbH Recent Developments
  67. 8.12 Biovencer Healthcare
  68. 8.12.1 Biovencer Healthcare Company Information
  69. 8.12.2 Biovencer Healthcare Business Overview
  70. 8.12.3 Biovencer Healthcare Bromhidrosis Disease Treatment Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Biovencer Healthcare Bromhidrosis Disease Treatment Product Portfolio
  72. 8.12.5 Biovencer Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bromhidrosis Disease Treatment Value Chain Analysis
  2. 9.1.1 Bromhidrosis Disease Treatment Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bromhidrosis Disease Treatment Sales Mode & Process
  6. 9.2 Bromhidrosis Disease Treatment Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bromhidrosis Disease Treatment Distributors
  9. 9.2.3 Bromhidrosis Disease Treatment Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst